Risultati della ricerca - Voravit Ratanatharathorn

  • Mostra 1 - 13 risultati su 13
Raffina i risultati
  1. 1
    Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

    Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody di Voravit Ratanatharathorn, Lois Ayash, C. Reynolds, Samuel Silver, Pavan Reddy, Michael A. Becker, James L.M. Ferrara, Joseph P. Uberti

    Pubblicazione 2003
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease

    Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease di Divaya Bhutani, Gregory Dyson, Richard Manasa, Abhinav Deol, Voravit Ratanatharathorn, Lois Ayash, Muneer H. Abidi, Lawrence G. Lum, Zaid Al‐Kadhimi, Joseph P. Uberti

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantation Patients

    High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantation Patients di Zaid Al‐Kadhimi, Zartash Gul, Wei Chen, Daryn Smith, Muneer H. Abidi, Abhinav Deol, Lois Ayash, Lawrence G. Lum, Edmund K. Waller, Voravit Ratanatharathorn, Joseph P. Uberti

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Effect of Increased Pigmentation on the Antifibrotic Response of Human Skin to UV-A1 Phototherapy

    Effect of Increased Pigmentation on the Antifibrotic Response of Human Skin to UV-A1 Phototherapy di Frank Wang, Luis A. Garza, Soyun Cho, Reza Kafi, Craig Hammerberg, Taihao Quan, Ted Hamilton, Maureen D. Mayes, Voravit Ratanatharathorn, John J. Voorhees, Gary J. Fisher, Sewon Kang

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

    Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age di Craig Kollman, Craig Howe, Claudio Anasetti, Joseph H. Antin, Stella M. Davies, Alexandra H. Filipovich, Janet Hegland, Naynesh Kamani, Nancy A. Kernan, Roberta King, Voravit Ratanatharathorn, Daniel J. Weisdorf, Dennis L. Confer

    Pubblicazione 2001
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

    Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis di David W. Denning, Kieren A. Marr, W. Lau, D. Facklam, Voravit Ratanatharathorn, Cornelia Becker, Andrew J. Ullmann, Nita L. Seibel, Patricia M. Flynn, Jo‐Anne H. van Burik, Donald N. Buell, Thomas F. Patterson

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease

    Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease di Joseph P. Uberti, Lois Ayash, Voravit Ratanatharathorn, Samuel Silver, C. Reynolds, Michael A. Becker, Pavan Reddy, Kenneth R. Cooke, Gregory A. Yanik, Joel Whitfield, Dawn Jones, Raymond J. Hutchinson, Thomas M. Braun, James L.M. Ferrara, John E. Levine

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

    Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantat... di Voravit Ratanatharathorn, Brent R. Logan, Dan Wang, Mary Horowitz, Joseph P. Uberti, Olle Ringdén, Robert Peter Gale, H. Jean Khoury, Mukta Arora, Stephen R. Spellman, Corey Cutler, Joseph H. Antin, Martin Bornhäuser, Gregory A. Hale, Leo F. Verdonck, Mitchell S. Cairo, Vikas Gupta, Steven Z. Pavletic

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

    Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma di John M. Timmerman, Andreas Engert, Anas Younes, Armando Santoro, Philippe Armand, Michelle A. Fanale, Graham P. Collins, Voravit Ratanatharathorn, John Kuruvilla, Jonathon B. Cohen, Kerry J. Savage, Marek Trněný, Jan Paul de Boer, Margaret A. Shipp, Scott J. Rodig, Kazunobu Kato, Anne Sumbul, Stephen M. Ansell

    Pubblicazione 2016
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

    Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial di Anas Younes, Armando Santoro, Margaret A. Shipp, Pier Luigi Zinzani, John M. Timmerman, Stephen M. Ansell, Philippe Armand, Michelle A. Fanale, Voravit Ratanatharathorn, John Kuruvilla, Jonathon B. Cohen, Graham P. Collins, Kerry J. Savage, Marek Trněný, Kazunobu Kato, Benedetto Farsaci, Susan Parker, Scott J. Rodig, Margaretha G.M. Roemer, Azra H. Ligon, Andreas Engert

    Pubblicazione 2016
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Effect of HLA-Matching Recipients to Donor Noninherited Maternal Antigens on Outcomes after Mismatched Umbilical Cord Blood Transplantation for Hematologic Malignancy

    Effect of HLA-Matching Recipients to Donor Noninherited Maternal Antigens on Outcomes after Mismatched Umbilical Cord Blood Transplantation for Hematologic Malignancy di Vanderson Rocha, Stephen R. Spellman, Mei-Jie Zhang, Annalisa Ruggeri, Duncan Purtill, Colleen A. Brady, Lee Ann Baxter‐Lowe, Étienne Baudoux, Paola Bergamaschi, Robert Chow, Brian M. Freed, Gesine Koegler, Joanne Kurtzberg, Jérôme Larghero, Lucilla Lecchi, Arnon Nagler, Cristina Navarrette, Vinod K. Prasad, Fabienne Pouthier, Thomas H. Price, Voravit Ratanatharathorn, Jon J. van Rood, Mary M. Horowitz, Éliane Gluckman, Mary Eapen

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

    National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide di Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel‐Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños‐Meade

    Pubblicazione 2021
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

    Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-... di Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel‐Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños‐Meade

    Pubblicazione 2022
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: